SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13D-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13D-2(a)

(Amendment No. 6)

Skystar Bio-Pharmaceutical Company

(Name of Issuer)

Common Stock

(Title of Class Of Securities)

830884102

(CUSIP Number)

John M. Gregory

SJ Strategic Investments, LLC

340 Martin Luther King, Jr. Boulevard, Suite 200

Bristol, TN 37620

(423) 989-8133

(Name, Address and Telephone Numbers of Person Authorized to Receive Notices and Communications)

May 26, 2015

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule l3D, and is filing this schedule because of Rule 13d l(e),13d l(f) or l3d-l(g), check the following box ¨

Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

(Continued on following pages)

(1)	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes)

13D


CUSIP No. 830884102		Page 2


1.	Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above Persons John M. Gregory
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC Use Only
4.	Source of Funds (See Instructions) OO
5.	Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e)
6.	Citizenship or Place of Organization United States of America
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power 765,150 (See Item 5)
		8.	Shared Voting Power 0
		9.	Sole Dispositive Power 765,150 (See Item 5)
		10.	Shared Dispositive Power 0
11.	Aggregate Amount Beneficially Owned by Each Reporting Person 1,231,150 (See Item 5)
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
13.	Percent of Class Represented by Amount in Row (11) 14.2%
14.	Type of Reporting Person (See Instructions) IN

13D


CUSIP No. 830884102		Page 3


1.	Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above Persons Joan P. Gregory
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC Use Only
4.	Source of Funds (See Instructions) OO
5.	Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e)
6.	Citizenship or Place of Organization United States of America
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power 257,400 (See Item 5)
		8.	Shared Voting Power 0 (See Item 5)
		9.	Sole Dispositive Power 257,400 (See Item 5)
		10.	Shared Dispositive Power 0 (See Item 5)
11.	Aggregate Amount Beneficially Owned by Each Reporting Person 765,150 (See Item 5)
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
13.	Percent of Class Represented by Amount in Row (11) 8.8%
14.	Type of Reporting Person (See Instructions) IN

13D


CUSIP No. 830884102		Page 4


1.	Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above Persons Susan Gregory
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC Use Only
4.	Source of Funds (See Instructions) OO
5.	Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e)
6.	Citizenship or Place of Organization United States of America
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power 0 (See Item 5)
		8.	Shared Voting Power 0 (See Item 5)
		9.	Sole Dispositive Power 0 (See Item 5)
		10.	Shared Dispositive Power 0 (See Item 5)
11.	Aggregate Amount Beneficially Owned by Each Reporting Person 507,750 (See Item 5)
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
13.	Percent of Class Represented by Amount in Row (11) 5.8%
14.	Type of Reporting Person (See Instructions) IN

13D


CUSIP No. 830884102		Page 5


1.	Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above Persons James M. Gregory
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC Use Only
4.	Source of Funds (See Instructions) OO
5.	Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e)
6.	Citizenship or Place of Organization United States of America
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power 466,000 (See Item 5)
		8.	Shared Voting Power 0 (See Item 5)
		9.	Sole Dispositive Power 466,000 (See Item 5)
		10.	Shared Dispositive Power 0 (See Item 5)
11.	Aggregate Amount Beneficially Owned by Each Reporting Person 973,750 (See Item 5)
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
13.	Percent of Class Represented by Amount in Row (11) 11.2%
14.	Type of Reporting Person (See Instructions) IN

13D


CUSIP No. 830884102		Page 6


1.	Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above Persons SJ Strategic Investments, LLC 30-0060195
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC Use Only
4.	Source of Funds (See Instructions) OO
5.	Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e)
6.	Citizenship or Place of Organization Tennessee
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power 507,750 (See Item 5)
		8.	Shared Voting Power 0
		9.	Sole Dispositive Power 507,750 (See Item 5)
		10.	Shared Dispositive Power 0
11.	Aggregate Amount Beneficially Owned by Each Reporting Person 507,750 (See Item 5)
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
13.	Percent of Class Represented by Amount in Row (11) 5.8%
14.	Type of Reporting Person (See Instructions) OO

13D


CUSIP No. 830884102		Page 6


1.	Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above Persons Kingsway Charities, Inc. 54-1668650
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC Use Only
4.	Source of Funds (See Instructions) OO
5.	Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e)
6.	Citizenship or Place of Organization Virginia
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power 466,000 (See Item 5)
		8.	Shared Voting Power 0
		9.	Sole Dispositive Power 466,000 (See Item 5)
		10.	Shared Dispositive Power 0
11.	Aggregate Amount Beneficially Owned by Each Reporting Person 466,000 (See Item 5)
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
13.	Percent of Class Represented by Amount in Row (11) 5.4%
14.	Type of Reporting Person (See Instructions) OO

Item 1.

Security and Issuer.

The title and class of equity securities to which this Schedule 13D/A relates is the common stock, par value $0.001 per share (the “Common Stock”), of Skystar Bio-Pharmaceutical Company (the “Issuer”). The Issuer’s principal executive offices are located at 4/F Building B, Chuangye Square, No. 48 Keji Road, Gaoxin District, Xi’an, Shaanxi Province, People’s Republic of China.

Item 2.

Identity and Background.

(a) This report is being filed by John M. Gregory and Joan P. Gregory, husband and wife, Susan Gregory, James M. Gregory, SJ Strategic Investments, LLC and Kingsway Charities, Inc. (collectively, the “Reporting Persons”). SJ Strategic Investments, LLC (“SJSI”) is a Tennessee limited liability company which has a principal business of engaging in investment activities. The members of SJSI are John M. Gregory, Joan P. Gregory, Susan Gregory and James M. Gregory. Susan Gregory and James M. Gregory are the children of John M. Gregory and Joan P. Gregory. Kingsway Charities, Inc. is a Virginia non-profit charitable organization for which John M. Gregory serves as Chairman of the Board of Directors.

(b)

The address for the Reporting Persons and the principal business office for SJSI is:

SJ Strategic Investments, LLC

340 Martin Luther King, Jr. Boulevard, Suite 200

Bristol, TN 37620

(c) John M. Gregory is the Managing Member of SJSI. Joan P. Gregory is a homemaker and is not presently employed in any other capacity. Susan Gregory is the Chief Investment Officer for SJSI. James M. Gregory is General Counsel of SJSI.

(d) and (e) None of the Reporting Persons has, during the last five years, (i) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting activities subject to, federal or state securities laws or finding any violation of such laws.

(f) John M. Gregory, Joan P. Gregory, Susan Gregory and James M. Gregory are citizens of the United States of America.

Item 3.

Source and Amount of Funds or Other Consideration.

SJSI acquired its shares of Common Stock with working capital of approximately $240,008. Kingsway Charities acquired its shares of Common Stock with working capital of approximately $1,343,720. John M. Gregory and Joan P. Gregory, as joint tenants with right of survivorship, acquired their shares of Common Stock with personal funds of approximately $357,257.

Item 4.

Purpose of Transaction.

The Reporting Persons have acquired the shares of Common Stock for investment purposes and may acquire additional shares or dispose of some or all of the shares of Common Stock, from time to time, depending upon price and market conditions, evaluation of alternative investments and other factors. The Reporting Persons intend to review on a continuing basis their investment in the shares of Common Stock, the Issuer’s business affairs and financial condition, as well as conditions in the securities markets and general economic and industry conditions.

None of the Reporting Persons has any plan or proposal which relates to or which would result in:

(a)

An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer:

(b)

The sale or transfer of a material amount of assets of the Issuer;

(c)

Any change in the present Board of Directors or management of the Issuer, including any plans or proposals to change the number or terms of Directors or to fill any existing vacancies on the Board;

(d)

Any material change in the present capitalization or dividend policy of the Issuer;

(e)

Any other material change in the Issuer’s business or corporate structure;

(f)

Changes in the corporate governance documents or other actions which may impede the acquisition or control of the Issuer by any person;

(g)

Causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an interdealer quotation system of a registered national securities association;

(h)

a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Exchange Act; or

(i)

Any action similar to any of those enumerated above.

Item 5.

Interest in Securities of Issuer

(a)

The calculations in this Item are based upon 8,696,942 shares of Common Stock issued and outstanding as of November 10, 2014 (based on disclosures made by the Issuer in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2014). As of the date hereof, the Reporting Persons beneficially owned 1,231,150 shares, or 14.2%, of the outstanding shares of Common Stock of the Issuer. The foregoing calculation is made pursuant to Rule l3d-3 promulgated under the Act.

(b)

Because John M. Gregory is the Managing Member of SJSI, he may be deemed to have the sole power to vote and direct the vote and the sole power to dispose and direct the disposition of the 507,750 shares held by SJSI. Neither Joan P. Gregory, Susan Gregory nor James M. Gregory presently have the power to dispose, direct the disposition, vote or direct the vote of Common Shares held by SJSI. Because James M. Gregory is the Chairman of Kingsway Charities, he has the sole power to vote and direct the vote and sole power to dispose and direct the disposition of the 466,000 shares held by Kingsway Charities. Neither John P. Gregory, Susan Gregory nor John M. Gregory presently have the power to dispose, direct the disposition, vote or direct the vote of Common Shares held by Kingsway Charities. However, they may be deemed to indirectly beneficially own shares of Common Stock of the Issuer held by SJSI due to their financial interests in SJSI. John M. Gregory and Joan P. Gregory control the voting and dispositive power of the 257,400 shares of Common Stock held by John M. Gregory and Joan P. Gregory as joint tenants with right of survivorship.

(c)

During the 60 day period ended as of the date hereof, the Reporting Persons have engaged in the following transactions, with all purchases and sales having been made for cash in the open market:

Reporting Person

Transaction

Date

No. of Shares

Average
Price Per Share

John M. Gregory

Purchase

05/26/2015

63,900

2.91

SJSI

Purchase

05/06/2015

50,000

3.47

SJSI

Purchase

04/16/2015

35,000

3.82

(d)

The Reporting Persons affirm that no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of the Issuer’s Common Shares beneficially owned by the Reporting Persons.

(e)

N/A

Item 6.

Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

The Reporting Persons do not have any contract, arrangement, understandings or relationships with respect to securities of the Issuer.

Item 7.

Material to be Filed as Exhibits.


Exhibit		Description

1*		Joint Filing Agreement

*	Filed as Exhibit 1 to the Reporting Persons’ Schedule 13D filed with the Securities and Exchange Commission on March 24, 2014.

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


Date: June 2, 2015		/s/ John M. Gregory
		John M. Gregory

		/s/ Joan P. Gregory
		Joan P. Gregory

		/s/ Susan Gregory
		Susan Gregory

		/s/ James M. Gregory
		James M. Gregory

		SJ Strategic Investments, LLC

		By: /s/ John M. Gregory
		John M. Gregory
		Its: Managing Member

		Kingsway Charities, Inc.

		By: /s/ John M. Gregory
		John M. Gregory
		Its: Chairman of the Board of Directors

SKYSTAR BIO-PHARMACEUTICAL CO SC 13D/A